MA35151B1 - Composés microarn et procédés pour la modulation de l'activité de mir-21 - Google Patents
Composés microarn et procédés pour la modulation de l'activité de mir-21Info
- Publication number
- MA35151B1 MA35151B1 MA36437A MA36437A MA35151B1 MA 35151 B1 MA35151 B1 MA 35151B1 MA 36437 A MA36437 A MA 36437A MA 36437 A MA36437 A MA 36437A MA 35151 B1 MA35151 B1 MA 35151B1
- Authority
- MA
- Morocco
- Prior art keywords
- activity
- mir
- methods
- microarn
- compounds
- Prior art date
Links
- 108091062762 miR-21 stem-loop Proteins 0.000 title abstract 5
- 108091041631 miR-21-1 stem-loop Proteins 0.000 title abstract 5
- 108091044442 miR-21-2 stem-loop Proteins 0.000 title abstract 5
- 230000000694 effects Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des compositions et des procédés pour l'inhibition de l'activité de mir-21. Les compositions ont certains motifs de modification de nucléoside qui fournissent des inhibiteurs puissants de l'activité de mir-21. Les compositions peuvent être utilisées pour inhiber mir-21 ainsi que pour traiter des maladies associées à une expression anormale de mir-21, telles qu'une fibrose et un cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161478767P | 2011-04-25 | 2011-04-25 | |
| PCT/US2012/034880 WO2012148952A1 (fr) | 2011-04-25 | 2012-04-25 | Composés microarn et procédés pour la modulation de l'activité de mir-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA35151B1 true MA35151B1 (fr) | 2014-06-02 |
Family
ID=51581886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA36437A MA35151B1 (fr) | 2011-04-25 | 2013-11-15 | Composés microarn et procédés pour la modulation de l'activité de mir-21 |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA35151B1 (fr) |
-
2013
- 2013-11-15 MA MA36437A patent/MA35151B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501065A1 (en) | Compounds and compositions useful for treating disorders related to ntrk | |
| TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
| MA41251B1 (fr) | Dérivés de thiéno[2,3-c]pyrrol-4-one comme inhibiteurs erk | |
| NZ730134A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
| MA43131B1 (fr) | Compositions et procédés d'inhibition de l'activité de l'arginase | |
| MA32393B1 (fr) | Composés et compositions servant d'inhibiteurs de kinases | |
| CA2871471C (fr) | Inhibiteurs d'adn pk | |
| TN2012000081A1 (en) | Compounds and compositions as protein kinase inhibitors | |
| MA39172B1 (fr) | Dérivés bicycliques hétérocycliques comme inhibiteurs de bromodomaines | |
| MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
| IN2014DN09134A (fr) | ||
| MY165728A (en) | Selective glycosidase inhibitors and uses thereof | |
| MD20140109A2 (ro) | Compuşi ai indolului şi indazolului care activează AMPK | |
| BR112012000968B8 (pt) | composto, composição e método para inibir uma fosfatidil inositol-3 cinase. | |
| IN2012DN03883A (fr) | ||
| MX365294B (es) | Inhibidores de proteína cinasa dependiente de adn. | |
| UY33597A (es) | Compuestos y composiciones como inhibidores de la trk | |
| MY171866A (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
| UA99936C2 (en) | Biaryl substituted azabicyclic alkane derivatives | |
| EA201291099A1 (ru) | Новые иммуномодуляторные и противовоспалительные соединения | |
| HN2010001647A (es) | INHIBIDORES DE HETEROCICLICOS DE ESTEAROIL-CoA-DESATURASA | |
| PH12013502516A1 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
| BR112014028042A2 (pt) | inibidores de nampt | |
| WO2013119946A8 (fr) | Inhibiteurs de la kinase sphingosine avec base à longue chaîne | |
| NI202100020A (es) | Inhibidores de pde4 que contienen boro |